Adhesive CapsulitisNCT07816679
GDS Method for Frozen Shoulder
A study testing GDS Muscle and Joint Chains Method and Conventional Physiotherapy in people with Adhesive Capsulitis and Frozen Shoulder, run by Anahuac University at 1 site in Mexico.
Trial summary
This randomized exploratory clinical trial evaluated the effectiveness of the GDS Muscle and Joint Chains Method compared with conventional physiotherapy in patients with frozen shoulder (adhesive capsulitis). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Adhesive Capsulitis, Frozen Shoulder
- What is being tested?
- GDS Muscle and Joint Chains Method and Conventional Physiotherapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteMexico
- Study dates
- 1 Jan 2021to 2 Aug 2023
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age >18 years.
- Diagnosis of frozen shoulder (adhesive capsulitis) established by a specialist in Traumatology and Orthopedics.
- Referral to the physiotherapy service.
- No current therapeutic assistance.
- Pharmacological treatment with NSAIDs and subacromial infiltration.
- Acceptance and signing of informed consent.
Who cannot join
- Contraindication to electrotherapy.
- Pacemaker.
- Metallic osteosynthesis material.
- Skin disorders in the area where electrodes would be applied.
- Current therapeutic assistance.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: GDS Muscle Chain Method Improved Movement and Pain Recovery in Frozen Shoulder Patients: An Exploratory Clinical Trial
This randomized exploratory clinical trial evaluated the effectiveness of the GDS Muscle and Joint Chains Method compared with conventional physiotherapy in patients with frozen shoulder (adhesive capsulitis). Thirty participants were randomly assigned to either the GDS intervention group or the conventional physiotherapy control group. Both interventions consisted of eight 50-minute sessions administered twice weekly for four weeks. The primary therapeutic objectives were to improve shoulder range of motion and reduce pain. Shoulder mobility was assessed using goniometry, and pain intensity was evaluated using a Visual Analog Scale. The study hypothesized that the GDS Muscle and Joint Chains Method would produce greater improvements in shoulder mobility and pain than conventional physiotherapy.
- Conditions
- Adhesive Capsulitis, Frozen Shoulder
- Being tested
- GDS Muscle and Joint Chains Method, Conventional Physiotherapy
- Medical subject headings
- Bursitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GDS Muscle and Joint Chains MethodOther
Participants received eight 50-minute sessions of the GDS Muscle and Joint Chains Method, administered twice weekly for four weeks. Treatment was individualized according to the participant's typology and included muscle reprogramming, postural and movement retraining, manual techniques applied along muscle-chain pathways, passive stretching, isometric and eccentric muscle activation, proprioceptive techniques, and strategies aimed at restoring balance between antagonistic and complementary muscle chains. Shoulder range of motion and pain intensity were assessed before and after the four-week intervention.
Conventional PhysiotherapyOther
Participants received eight 50-minute conventional physiotherapy sessions administered twice weekly for four weeks. Treatment included application of a hot compress to the affected shoulder, 15 minutes of conventional transcutaneous electrical nerve stimulation (TENS) at 150 Hz with intensity adjusted to participant tolerance, 10 minutes of therapeutic ultrasound at 3 MHz and 0.8 W/cm² in pulsed mode at 50%, followed by 15 minutes of therapeutic exercise according to the MEDBRIDGE GO program. Shoulder range of motion and pain intensity were assessed before and after the intervention.
| Study group | Role | What they receive |
|---|---|---|
| GDS Muscle and Joint Chains Method | Experimental | Not described Receives: Other: GDS Muscle and Joint Chains Method |
| Conventional Physiotherapy | Active comparator | Not described Receives: Other: Conventional Physiotherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Shoulder Range of Motion
Shoulder range of motion was measured in degrees using goniometry. Measurements included shoulder flexion, abduction, internal rotation, external rotation at 90° of abduction, and external rotation at 0°.
Measured: Baseline and 4 weeks
Change in Pain Intensity
Pain intensity was assessed using a Visual Analog Scale ranging from 0 to 10, with 0 representing no pain and 10 representing the greatest pain intensity.
Measured: Baseline and 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2026
- Study start1 Jan 2021
- Primary completion1 Aug 2023
- Study completion2 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adhesive CapsulitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Anahuac University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jose Juan Antonio Ibarra Arias, Anahuac University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07816679
- Sponsor's protocol ID
- CEI202207
- Status last verified
- Sep 2026
- First submitted
- 7 Sep 2026
- Last updated
- 15 Sep 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No